Overview of testing for SARS-CoV-2

Updated Aug. 24, 2020Note: This document is intended to provide guidance on the appropriate use of testing among nursing home residents and healthcare personnel and does not dictate the determination of payment decisions or insurance coverage of such testing, except as may be otherwise referenced (or prescribed) by another entity or federal or state agency.his document provides a summary of considerations and current Centers for Disease Control and Prevention (CDC) recommendations regarding SARS-CoV-2 testing. The CDC recommendations for SARS-CoV-2 testing have been developed based on what is currently known about COVID-19 and are subject to change as additional information becomes available.Changes noted were made in a retired document, \u201cEvaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19),\u201d which has been replaced by this Overview of Testing for SARS-CoV-2. See more changes.Recommendations for Viral Testing, Specimen Collection, and Reporting -- Recommendations for Antibody Testing -- Categories for SARS-CoV-2 Testing -- Recommended testing for individuals with signs or symptoms consistent with COVID-19 -- Recommended testing for asymptomatic individuals with known or suspected exposure to SARS-CoV-2 to control transmission -- Recommended testing for asymptomatic individuals without known or suspected SARS-CoV-2 exposure for early identification in special settings -- Recommended testing to determine resolution of infection with SARS-CoV-2 -- Public health surveillance for SARS-CoV-2 -- Additional Resources -- Summary of Changes to Retired Document, \u201cEvaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19)\u201d.2020864